PR Emerges as the Primary Source for Journalists in High-Pressure Newsrooms

13.05.2026

Cision's 2026 State of the Media Report reveals 66% of journalists rely on PR for story ideas

CHICAGO, May 13, 2026 /PRNewswire/ -- Cision, a global leader in consumer and media intelligence, today released its 2026 State of the Media Report, revealing a shift in how the media ecosystem operates: PR is no longer just pitching stories, it's becoming a critical part of how the modern newsroom works.

Cision’s 2026 State of the Media Report features insights from 1,800+ journalists worldwide.

Based on a global survey of nearly 2,000 journalists across 19 markets, the report finds that 66% of journalists rely on PR-provided content – including press releases, pitches, and media kits – for story ideas, making PR the leading source of story leads.

More information. More pressure.

Journalists are working across a more fragmented media landscape, and competing with creators and AI for audience attention. At the same time, newsroom constraints continue to grow:   

  • Accuracy, fact-checking, and combating misinformation emerged as the No. 1 challenge journalists face today
  • 49% cite shrinking budgets, staff cuts, and increased workloads as their biggest obstacles

These trends point to a shift in how journalists and PR professionals work together, with journalists placing greater reliance on PR teams that can provide timely, relevant, and credible information.

"The 2026 report makes one thing clear: The newsroom and PR professionals are more interdependent than ever," said Amy Jones, Chief Marketing Officer at Cision. "As journalists face unprecedented pressure on their time and resources, PR is becoming an essential partner, providing data, ideas, and expert access that helps support the news cycle."

Key insights

  • Relevance is the biggest gap

    72% of journalists say fewer than a quarter of pitches are relevant
  • LinkedIn is the most valuable platform for media

    62% use LinkedIn professionally, with 33% ranking it as the single most valuable platform for their work
  • AI is growing, but trust matters

    53% oppose AI-generated pitches due to concerns around accuracy and personalization
  • What journalists value most in pitches

    Original research, expert access, and embargoed information

What this means for PR

As AI becomes more embedded in newsrooms, generic outreach is losing impact.

Journalists are clear on what works: Relevant ideas, original research, credible data, expert access, and ready-to-use assets.

PR teams that support how journalists work, not just pitch them stories, are the ones that stand out.

In a faster, more fragmented media environment, clarity, and credibility, not volume, drive impact.

Download the 2026 State of the Media Report

Cision is following the report's release with a two-part webinar series featuring a panel of journalists who will unpack the findings and answer audience questions. Register for free

About the 2026 State of the Media Report

Cision's State of the Media Report has served as a trusted benchmark for more than a decade, helping communications professionals understand journalists' preferences, challenges, and evolving workflows.

The 2026 report is based on a survey conducted in January and February 2026 of 1,899 journalists across North America, EMEA, and APAC, representing digital publications, newspapers, magazines, broadcast outlets, and emerging media platforms.

About Cision

Cision is the global leader in consumer and media intelligence, engagement, and communication solutions. We equip PR and corporate communications, marketing, and social media professionals with the tools they need to excel in today's data driven world. Our deep expertise, exclusive data partnerships, and award-winning products, including CisionOneBrandwatch, Trajaan, and PR Newswire, enable over 75,000 companies and organizations, including 84% of the Fortune 500, to see and be seen, understand and be understood by the audiences that matter most to them.

Media Contact: 

Cision Public Relations 

CisionPR@cision.com

Cision

Photo - https://mma.prnewswire.com/media/2976923/Cisions_2026_State_of_the_Media_Report.jpg

Logo - https://mma.prnewswire.com/media/2075643/cisionlogo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pr-emerges-as-the-primary-source-for-journalists-in-high-pressure-newsrooms-302770952.html

Other news

Sandoz behauptet sich in verzerrtem Antibiotika-Markt und hält an Guidance fest

30.04.2026

Sandoz hat im ersten Quartal 2026 trotz erheblicher Verwerfungen im Penicillin-Geschäft weiteres Wachstum erzielt. Der Umsatz des Schweizer Generika- und Biosimilar-Spezialisten belief sich zwischen Januar und März auf 2,76 Milliarden US-Dollar, ein Plus von 11 Prozent gegenüber dem Vorjahreszeitraum. Zu konstanten Wechselkursen legten die Erlöse um 3 Prozent zu. Der Konzern bestätigt nach eigenen Angaben seinen Ausblick für das Gesamtjahr.

Treiber der Entwicklung war vor allem das höhermargige Biosimilar-Geschäft, das die frühere Novartis-Tochter weiter ausgebaut hat. Dagegen stand die grössere Generika-Sparte erneut unter Druck, weil sich die Marktverwerfungen im Penicillin-Segment fortsetzten. Klammerte man die negativen Auswirkungen aus dem Antibiotika-Geschäft aus, hätte das Umsatzplus zu konstanten Wechselkursen bei rund 5 Prozent gelegen und damit im Rahmen der Unternehmensprognose.

Die Belastungen resultieren aus einem anhaltenden Preisverfall bei wichtigen Penicillin-Wirkstoffen (Active Pharmaceutical Ingredients), der bereits im Vorjahr eingesetzt hatte. Hintergrund sind US-Zölle, die chinesische Anbieter dazu veranlasst haben, ihre Penicillin-Mengen verstärkt nach Europa umzuleiten. Das zusätzliche Angebot hat dort die Preise deutlich gedrückt. Parallel dazu führten in Indien eingeführte Mindestpreisvorschriften dazu, dass weniger chinesische Ware in diesen Markt floss, was den Wettbewerbsdruck in Europa zusätzlich verschärfte und den Preisdruck weiter verstärkte.

Laut Sandoz konzentrieren sich die heftigsten Auswirkungen dieser Entwicklung auf das erste Quartal, die verbleibenden Effekte sollen sich nun schrittweise abschwächen. Analysten verweisen darauf, dass das Unternehmen ohne den Antibiotika-Gegenwind im Rahmen seiner Guidance gewachsen wäre. Der Konzern bleibt damit auf Wachstumskurs, muss sich im Generika-Kerngeschäft jedoch weiterhin in einem von handelspolitischen Eingriffen und regulatorischen Änderungen verzerrten Marktumfeld behaupten.